Hackensack University Medical Center Announces Three Clinical Trials to Improve Urological Care in Women
Researchers Address Problems with Urination and Recurrent UTIs
Investigators in Female Pelvic Medicine at Hackensack University Medical Center Department of Urology have completed two studies and are conducting a third aimed at improving the standard of care for common urologic disorders in women. The studies address voiding dysfunction (problems with urination) and the management of urinary tract infections (UTIs) and have yielded compelling data that will be presented at professional conferences and published in academic medical journals.
“Problems with urination and UTIs impact the health and quality of life of many women. My colleagues and I are leading innovative clinical trials aimed at improving the care of these women and optimizing their outcomes,” explained Debra Fromer, M.D., chief of Female Pelvic Medicine and Reconstructive Surgery at Hackensack University Medical Center.
Studies led by Dr. Fromer are answering critical questions in treatment of these common urological problems, including the ability of patients with voiding dysfunction to predict voiding and post-void residual volumes, the role of cystoscopy in the management of women with recurrent UTIs, and trends in microbial resistance among women with recurrent UTIs.
Experts in the Female Pelvic Medicine and Reconstructive Surgery division at Hackensack University Medical Center are leaders in the management of urogynecologic issues and offer the latest treatments and technologies. Examples include the use of Bulkamid®, a "bulking agent" that is injected into the urethra under a local anesthetic in a doctor's office that has been shown to help women with stress incontinence ("leaky bladder"), and new techniques for sacral neuromodulation for the treatment of overactive bladder, urinary retention, and fecal incontinence.
Learn more about urology advancements happening at Hackensack Meridian Hackensack University Medical Center.